Nexgel (NXGL) EBITDA Margin Growth (3y) (2021 - 2025)
Nexgel (NXGL) EBITDA Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 473.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1,105.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 800.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -71.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -1,411.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -1,216.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -51.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -284.00 |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | 20,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,377.00 |
| Sep 30, 2025 | 15,786.00 |
| Jun 30, 2025 | 10,593.00 |
| Mar 31, 2025 | 17,736.00 |
| Dec 31, 2024 | 13,876.00 |
| Sep 30, 2024 | 15,529.00 |
| Jun 30, 2024 | 5,942.00 |
| Mar 31, 2024 | 12,596.00 |
| Dec 31, 2023 | 55,665.00 |
| Sep 30, 2023 | 17,095.00 |
| Jun 30, 2023 | 52,811.00 |
| Mar 31, 2023 | 6,966.00 |
| Dec 31, 2022 | 2,880.00 |
| Sep 30, 2022 | -20,835.00 |
| Mar 31, 2022 | 26,937.00 |
| Dec 31, 2021 | -2,347.00 |
| Sep 30, 2021 | 3,458.00 |